相关实验视频

Updated: Jun 26, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

来自瘤的抗原作为潜在的癌症疫苗

Stanislav Sotirov¹, Ivan Dimitrov¹

¹Drug Design and Bioinformatics Lab, Faculty of Pharmacy, Medical University of Sofia, 2, Dunav Str., 1000 Sofia, Bulgaria.

International journal of molecular sciences

|May 11, 2024

概括

类癌症疫苗通过向瘤特异性抗原 (TSAs) 和瘤相关抗原 (TAAs) 来预防和根除瘤有希望. 目前正在进行的研究和临床试验正在探索它们的疗效和新的输送方法,以改善癌症治疗.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
疫苗学疫苗学疫苗学

背景情况:

来自瘤的类抗原,分为瘤相关抗原 (TAA) 或瘤特异性抗原 (TSA),可以触发保护性免疫反应.
使用这些抗原的亚单元癌症疫苗已经证明了癌症预防和根除的潜力.
基于的癌症疫苗越来越多地被用作治疗策略,通常与其他癌症治疗一起使用.

研究的目的:

为提供基于的癌症疫苗近期进展的概述.
总结瘤新抗原预测的计算方法.
审查正在进行的临床试验和人类疫苗接种实验.

主要方法:

关于基于的癌症疫苗的现有文献的审查.
对新抗原鉴定的计算方法的总结.
对临床试验和疫苗接种研究数据的分析.

主要成果:

基于的癌症疫苗是一种有前途的治疗方法,在临床试验中取得了积极的结果.
测序技术和in silico方法的进步提高了抗原的识别.
新的输送系统和对瘤免疫逃避机制的理解正在改善疫苗开发.

结论:

基于的疫苗代表了癌症免疫疗法的重大进步.
对新抗原预测,输送方法和免疫规避的持续研究至关重要.
类疫苗对未来的癌症治疗策略具有相当大的前景.

关键词:

抗原是一种抗原.生物信息学是一种生物信息学.癌症癌症癌症癌症癌症免疫性免疫性免疫性疫苗疫苗疫苗疫苗

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...